The use of this advanced computer will be addressed to scientific centers engaged in medical research.
This supercomputer will be based on the ARM architecture, as already announced by the company, while it will be named Cambridge-1, which obviously matches the geographical location where it will be placed. The first information wants this computer center to have the ability to perform calculations of 400 petaflops, which means that it will be able to run Artificial Intelligence applications.
It is worth noting that the performance mentioned by Nvidia, ranks the system in 29th place in the list of the most powerful computer systems in the world, while it is in 3rd place in the list of the most energy efficient supercomputers on the planet.
This investment by Nvidia will cost $ 51.7 million, so it can not be said that this is a simple case. On the other hand, it is obvious that the company wants to give a respectable part of its financial resources for the development of medical research.
It is worth noting that this is the first time that Nvidia has been involved in such an ambitious research project, which includes enhancing research by giving researchers, scientists and academics a range of sophisticated tools for their research needs.
GlaxoSmithKline and AstraZeneca will be some of the pharmaceutical companies estimated to benefit from the advanced capabilities of the new research center. We know the second company well from its involvement in the production of the vaccine for Covid-19 disease. Therefore, Nvidia’s decision to invest in 2020 in the creation and installation of this supercomputer is of particular interest.